The “Ross procedure” may be a more favourable option for aortic valve replacement among patients under 50 years old than more standard mechanical or biological replacements, according to a study published in the Journal of the American College of Cardiology (JACC).

Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective analysis of patients treated at a single centre in Winnipeg, Canada has concluded.

Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with detectors optimised in size for integrated use in the cath lab.

Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospital mortality, but higher 30-day and six-month all-cause readmission than repeat surgical aortic valve replacements (SAVR) in patients with a failed aortic bioprosthetic valve.

Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospital mortality, but higher 30-day and six-month all-cause readmission than repeat surgical aortic valve replacements (SAVR) in patients with a failed aortic bioprosthetic valve.

The donation of new 3D printing technology to the Visible Heart Laboratories at the University of Minnesota (Minneapolis, USA) will aid the training of future cardiologists and medical device development by producing anatomic models that replicate a patients’ heart anatomy and pathology.

Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled trial (RCT), evaluating the Dynamx coronary bioadaptor system, a drug-eluting coronary artery implant that adapts to vessel physiology, allowing for the restoration of normal vessel functions.

Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a company that offers advanced transseptal access solutions as well as guidewires, sheaths and dilators used to support catheter-based left-heart procedures.

Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adverse cardiovascular event as a result of thoracic radiation therapy compared to patients with no coronary artery calcium. This is according to the findings of a study being presented at the American College of Cardiology’s (ACC’s) Advancing the Cardiovascular Care of the Oncology Patient course (11‒12 February, virtual).

The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long lesions improved long-term cardiac survival compared with angiography-guided implantation. This is according to the findings of a patient-level data meta-analysis, published in JACC: Cardiovascular Interventions.

The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxford, UK)—is the first in the UK to use photon-counting CT, a high resolution and dose reduction technology. The NAEOTOM Alpha (Siemens Healthineers) is also the first in the world to sit within a hybrid catheterisation laboratory, Siemens said in a press release.

Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave Doppler technology to expand the haemodynamic assessment and measurement capabilities of the system.